Pharmaceutical and biotechnology major Wockhardt has launched Midazolam injection in the United States. Wockhardt received this approval tram the United States Food & Drug Administration (US FDA) for marketing the preservative-tree version injections containing 1 mg/ml and 5mg/ml Midazolam, which is used for treating acute insomnia and anxiety. Wockhardt had earlier received the US FDA approval for the injection containing preservatives. Midazolam is the generic name for the brand Versed. According to IMS, the total market far Midazolam injections in the US is $56 million.
The company made this announcement during the trading hours today, 14 November 2008.
1 comment:
In this article we shall be discussing about the various ways in which one can make as much profits as maybe possible and how we can select securities to make investments. Investing in securities can be profitable only if investment is done with proper research
Post a Comment